US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ARQL

ArQule (ARQL)

ArQule Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ARQL

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2020/02/15	07 : 35	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARQL	ArQule Inc
2020/02/15	02 : 20	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ARQL	ArQule Inc
2020/02/13	07 : 03	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARQL	ArQule Inc
2020/02/13	02 : 05	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARQL	ArQule Inc
2020/02/11	03 : 43	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARQL	ArQule Inc
2020/02/06	01 : 29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARQL	ArQule Inc
2020/01/28	03 : 55	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:ARQL	ArQule Inc
2020/01/21	20 : 00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ARQL	ArQule Inc
2020/01/21	20 : 00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ARQL	ArQule Inc
2020/01/21	20 : 00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ARQL	ArQule Inc
2020/01/07	01 : 07	PR Newswire (US)	Moore Kuehn, PLLC Encourages Investors of KEM, ARQL, THOR, and LOGM to Contact the Firm	NASDAQ:ARQL	ArQule Inc
2019/12/13	05 : 49	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates ArQule, Inc.	NASDAQ:ARQL	ArQule Inc
2019/12/10	17 : 02	Dow Jones News	Merck, Sanofi Push To Add Cancer Drugs -- WSJ	NASDAQ:ARQL	ArQule Inc
2019/12/10	09 : 16	Dow Jones News	Big Drugmakers Push Deeper Into Cancer Treatment -- 4th Update	NASDAQ:ARQL	ArQule Inc
2019/12/10	06 : 37	Dow Jones News	Big Drugmakers Push Deeper Into Cancer Treatment -- 3rd Update	NASDAQ:ARQL	ArQule Inc
2019/12/10	05 : 12	Dow Jones News	U.S. Stocks Slip as Trade War Weighs on Chinese Exports	NASDAQ:ARQL	ArQule Inc
2019/12/10	04 : 33	Dow Jones News	Big Drugmakers Push Deeper Into Cancer Treatment -- 2nd Update	NASDAQ:ARQL	ArQule Inc
2019/12/10	01 : 13	Dow Jones News	Merck to Buy ArQule for $2.7 Billion -- Update	NASDAQ:ARQL	ArQule Inc
2019/12/09	22 : 05	Business Wire	ArQule Announces Final Phase 1 Clinical Data for Its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology...	NASDAQ:ARQL	ArQule Inc
2019/12/09	21 : 37	PR Newswire (US)	(ARQL) Alert: Johnson Fistel Investigates Proposed Sale of ArQule, Inc.; Is $20 a Fair Price?	NASDAQ:ARQL	ArQule Inc
2019/12/09	21 : 26	Dow Jones News	Merck to Buy ArQule for $2.7 Billion, or $20/Share	NASDAQ:ARQL	ArQule Inc
2019/12/09	20 : 45	Business Wire	Merck to Acquire ArQule, Advancing Leadership in Oncology	NASDAQ:ARQL	ArQule Inc
2019/11/25	21 : 00	Business Wire	ArQule to Present Clinical Data for its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology 2019 Annual ...	NASDAQ:ARQL	ArQule Inc
2019/11/13	21 : 00	Business Wire	ArQule to Participate in the Jefferies London Healthcare Conference on November 20, 2019	NASDAQ:ARQL	ArQule Inc
2019/11/06	23 : 05	Business Wire	ArQule Announces Release of American Society of Hematology Abstract Detailing Results of the Ongoing Phase 1 Study of Reversi...	NASDAQ:ARQL	ArQule Inc
2019/10/30	23 : 57	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ARQL	ArQule Inc
2019/10/30	20 : 30	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARQL	ArQule Inc
2019/10/30	20 : 00	Business Wire	ArQule Reports Third Quarter 2019 Financial Results	NASDAQ:ARQL	ArQule Inc
2019/10/30	05 : 01	Business Wire	ArQule Presents Recent Data on ARQ 751 at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets & Cancer Ther...	NASDAQ:ARQL	ArQule Inc
2019/10/21	20 : 00	Business Wire	ArQule Announces Preclinical Data Demonstrating Potential of Miransertib (ARQ 092) to Treat PIK3CA-Driven Vascular Malformati...	NASDAQ:ARQL	ArQule Inc

Showing the most relevant articles for your search:NASDAQ:ARQL

1 2 3 4 5 6 7 8 9 10 次へ >>

Health Care Select Sector

Financial Select Sector

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約